Clinical Pharmacokinetics of Irinotecan-Based Chemotherapy in Colorectal Cancer Patients

By  

Current Clinical Pharmacology, Vol. 1, Iss. 3, 2006-09 ,pp. : 311-323

Bentham Science Publishers

Access to resources Recommend Favorite

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

By Shin Sang  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 672-680

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemo before stem cell transplantation for paediatric HD

By  

Inpharma, Vol. 1, Iss. 1472, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Gemcitabine/irinotecan/oxaliplatin: Various toxicities in paediatric patients: 10 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1366, 2011-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Melphalan-based chemo regimens for light-chain amyloidosis

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite